Table 1 Program and Session Facilitators
From: "Harnessing genomics to improve health in India" – an executive course to support genomics policy
Time | Day 1 | Day 2 | Day 3 | Day 4 |
|---|---|---|---|---|
9:00 – 10:30 | Introduction and Course Overview Dr Vasantha Muthuswamy – ICMR Dr Peter A. Singer – University of Toronto Dr Abdallah S. Daar – University of Toronto | Ethical guidelines for Medical Research in India Dr N.K. Ganguly – ICMR | Intellectual Property Rights Dr Malathi Lakshmikumaran – TERI | Opinion Leaders' Network Dr Peter A. Singer Dr Rakesh Dubey – Ocimum Biosolutions |
11:00–12:30 | New Science 1 : Genomics Dr S. S. Agarwal – ACTREC DNA Vaccines – Relevance for India Dr G. Padmanabhan – IISc | Business Models Dr Chandu Nair – Scope Marketing & Knowledge National Systems of Innovation Dr Peter A. Singer | Public Health – Community Ownership Dr Saraswathi Sankaran – DESH | |
2:00–3:30 | New Science 2 : Stem Cells Dr Dipika Mohanty – ICMR (Institute of Immunohaematology) | Indian Business Perspectives Mr Khalil Ahmed – Shanta Biotech Dr Krishna Ella – Bharath Biotech | Group Presentations Biotechnology: From Benches to Bedside Dr Rajesh Behl – Centre for Human Genetics | Group Presentations |
4:00–5:30 | Genomics and Global Health Dr Abdallah S. Daar | Pharmaco-genomics Dr C. M. Gupta – CDRI Dr Vasantha Muthuswamy Dr R. H. Jani – German Remedies | Legal Regulations of Genomics – Emerging Scenario Dr Madhava Menon – WB National University of Juridical Sciences | Summing up Dr Sandhya Tewari – CII Discussion & Closing – Dr Peter A. Singer |